InvestorsHub Logo
Followers 12
Posts 1139
Boards Moderated 0
Alias Born 02/13/2018

Re: bwolfy2002 post# 133523

Monday, 12/14/2020 10:59:07 PM

Monday, December 14, 2020 10:59:07 PM

Post# of 233586
No other therapeutic option has even come close. This one has completed its study enrollment and is on the verge of meeting its primary endpoint (mortality!) and already boasts an impressive safety profile. All this plus the clinical indication is for relief during a worldwide pandemic.

If the unblinded data proves statistically significant results, there is zero percent chance this isn’t approved by end of Q1. IMO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News